Custom intermediate supply following Trelleborg reformulation

Trade Flow · Identified

5 agents · last run 01:22 todayDraft outreach

$5.2Mestimated value

2/5roles covered

3sources behind the signal

Identifiedstage

Mediumrelevance · ranked 19 of 29

Why this exists

This puts a competitor-held position in play for the first time in four years.

The chain

what produced this, and what it still needs

1 · Signal

Recall exposure in Trelleborg's Medical Solutions unit is forcing a reformulation review

Pressure Points · 3 sources Low confidence

2 · Opportunity

Scored 19 of 29 surfaced · $5.2M

Above the relevance bar 182 scored, 29 surfaced

you are here

3 · People

2 of 5 roles mapped

4 · Draft

Not started

Win Kit is ready — 3 proof points and a competitive counter.

in your licence

Value hypothesis

Qualification time is the binding constraint, not price.

Proof points

Competitive counter

Incumbent is Freudenberg; their grade does not clear the new limit.

Commercial angle

Lead with a paid trial to compress the qualification decision.

2 of 5 roles covered

Buys it

Nobody mapped · Procurement